Status:
COMPLETED
Study of Evaluation Indexes for Antibody Production in Sera After Immunization
Lead Sponsor:
Ewha Womans University
Conditions:
Aged
Eligibility:
All Genders
2-90 years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate analytical methods such as ELISA and OPKA that measure the activity of vaccine-induced pneumococcal antibodies. After validation of ELISA and OPKA, pneumococcal an...
Detailed Description
To evaluate the immune response to the pneumococcal polysaccharide vaccine in the elderly, samples from children, young adults and elderly were obtained before and one month after vaccination. The qua...
Eligibility Criteria
Inclusion
- elderly subjects over the age 65 years who had not received pneumococcal vaccination
- adult subjects under the age of 45 years (healthy volunteers with no previous history of pneumococcal vaccination)
- children subjects over the age of 2 years with no previous history of pneumococcal vaccination
Exclusion
- immunocompromised, asplenia, cancer, liver or renal failure, and history of hypersensitivity to vaccine
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00964769
Start Date
April 1 2005
End Date
June 1 2005
Last Update
August 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ewha Womans University Dongdaemun Hospital
Seoul, Seoul, South Korea, 110-125